Registry of Lobbyists
| Corporation: | Vertex Pharmaceuticals (Canada) Incorporated |
| Associated registration: | 945696-366162-5 |
| Communication date: | 2023-07-04 |
| Posted date: | 2023-08-15 |
| Designated Public Office Holders who participated in the communication: |
Andrew Taylor,
Senior Policy Advisor
Health Canada (HC) Josee Leblanc, Senior Policy Advisor Health Canada (HC) Daniel MacDonald, Director General, Drugs for Rare Diseases Strategic Policy Branch, Health Canada (HC) Christine Ung, Policy Advisor Health Canada (HC) |
| Subject Matter of the communication: | Health, Research and Development, Science and Technology |
| Responsible Officer who filed this communication report: | Michael Siauw |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |